{"id":"W2560819401","doi":"10.1182/blood.v104.11.866.866","title":"A Multicentre, Double-Blind, Randomized, Phase 2 Trial Comparing Pegfilgrastim with Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Filgrastim; Pegfilgrastim; Medicine; Cytarabine; Chemotherapy; Febrile neutropenia; Neutropenia; Idarubicin; Induction chemotherapy; Internal medicine; Granulocyte colony-stimulating factor; Surgery; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002479234,0.001963243,0.00322705,0.000524956,0.0005297614,0.001178101,0.001213489,0.00246516,0.007133989],"category_scores_gemma":[0.002279118,0.0009466553,0.001269944,0.0004724775,0.001546195,0.001164187,0.000586535,0.003432615,0.001479073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007785176,"about_ca_system_score_gemma":0.001457154,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006876211,"about_ca_topic_score_gemma":0.001434565,"domain_scores_codex":[0.9990247,0.000563916,0.00005024762,0.0001801882,0.00005962769,0.0001211666],"domain_scores_gemma":[0.9986198,0.0004079272,0.000308702,0.0001251566,0.00007331296,0.0004650547],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.986751,0.006927025,0.0001767217,0.0002030171,0.0001930809,0.00001620133,0.00001964771,0.00008862622,0.001508459,0.00004696903,0.0002786737,0.003790666],"study_design_scores_gemma":[0.9570673,0.04205154,0.0003709096,0.000007374157,0.00006627033,0.000008493457,0.000004428574,0.0001016828,0.0001181521,0.00003837463,0.0001613918,0.00000401686],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9821821,0.002808252,0.00084488,0.0009630699,0.00103686,0.009120525,0.001007935,0.0001643319,0.00187208],"genre_scores_gemma":[0.977264,0.001662638,0.002687611,0.002026989,0.000805455,0.009895661,0.001235256,0.00003106987,0.00439123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007133989,"threshold_uncertainty_score":0.02386558,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03301226243484864,"score_gpt":0.3518987898533572,"score_spread":0.3188865274185085,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}